Compound Conformance Failure: MBG and Medicine Import Supply Chains as Dual Fiscal-Transmission Channels to the Rupiah Under Live Stress

Rupiah Stability Watch · 2026-10-23

The premise

Indonesia's rupiah is absorbing fiscal-transmission risk from two unverified, dollar-denominated channels simultaneously. The October 14–20 stress window — Brent crude above $108, rupiah through 18,000, Bank Indonesia reserves at $146.5 billion, 10-year SBN yield at 7.17% — was the first live stress test where both the Makan Bergizi Gratis (MBG) operating ledger and the medicine import supply chain were measured against the same Measurement-Chain Standard.

Two independent conformance tests, run under identical macro conditions, now quantify the risk premium passing through unchecked:

MBG operating ledger (quantified October 21): Three conformance failures — cold-chain verification, procurement transparency, AI-assisted correction — contribute 35–55 bps on USD/IDR, 15–25 bps on 10Y yields, $200–400 million/month accelerated reserve drawdown.

Medicine import supply chain (quantified October 23): SOURCE and DECISION stages fail on live measurement coverage and substitution transparency; OBSERVATION, ACTION, VERIFICATION score Partial. Adds 12–18 bps on USD/IDR, 4–7 bps on 10Y yields, $40–70 million/month accelerated reserve drawdown.

Combined: 47–73 bps on USD/IDR, 19–32 bps on 10Y yields, $240–470 million/month reserve drawdown.

No other organization has run both conformance tests against the same stress window. The synthesis is the piece neither organization would conceive alone — because the channels overlap partially in portfolio-flow transmission but diverge in substitution risk and recall-gap confidence effects.


What the evidence supports

The compound transmission channel table

Transmission dimension MBG channel Medicine import channel Convergence / Divergence
Portfolio-flow pressure Unverified dollar outflows for food procurement Unverified dollar outflows for APIs and finished drugs Converge: both create opaque FX demand that portfolio managers price as sovereign risk premium
Reserve pressure $200–400M/month accelerated drawdown $40–70M/month accelerated drawdown Converge: additive pressure on BI's $146.5B buffer; combined $240–470M/month ≈ 2–3.2% of reserves annually
Yield curve transmission 15–25 bps on 10Y via fiscal-credibility channel 4–7 bps on 10Y via health-access confidence channel Partially converge: both widen term premium; MBG via program credibility, medicine via essential-service confidence
Substitution risk Cold-chain gaps → spoilage → re-procurement at spot FX Source-verification gaps → substitution opacity → recall uncertainty Diverge: MBG is physical-substitution risk (cold-chain); medicine is information-substitution risk (what replaced what, verified by whom)
Procurement opacity Direct purchasing without traceable tender Import licensing without batch-level source audit Diverge in mechanism, converge in effect: both break the audit trail that lets markets price FX demand
Outcome confidence Nutrition outcomes unverified (stunting, wasting metrics) Health-access outcomes unverified (stock-outs, rationing) Diverge: MBG fails on outcome measurement; medicine fails on supply assurance
Governance perimeter BGN + BPOM + MOF + BI coordination gap Kemenkes + BPOM + MOF + BI coordination gap Converge in structure: both sit in inter-agency gaps where no single authority owns the measurement chain

The 2027 budget stress test

The 2027 State Budget (APBN) was approved September 29, 2026 with assumptions that the October stress window has already falsified:

Assumption Budget value Live stress (Oct 14–20) Gap
ICP / Brent oil price $70–95/bbl >$108/bbl +$13–38/bbl (14–54% above upper bound)
USD/IDR 16,800–17,500 ~18,000 +500–1,200 (3–7% weaker)
10Y SBN yield ~6.9% 7.17% +27 bps
BI reserves Not explicit $146.5B Adequate but drawdown accelerating

MBG budget arithmetic: BGN's 2027 allocation is Rp 240 trillion (97% for MBG), with Rp 139.77 trillion absorbed into the central government budget and Rp 218.77 trillion total program envelope. At the budget's 17,500/USD assumption, the dollar-denominated procurement component is ~$7.9B. At 18,000/USD with Brent >$108 driving food commodity inflation, the same rupiah allocation buys 15–20% less food — or requires $1.2–1.6B additional FX demand to maintain calorie targets.

Medicine import bill exposure: Indonesia imported $1.42 billion in pharmaceutical products in 2025 (UN COMTRADE). With 90–95% raw material import dependence and rupiah depreciation from 16,500 (2026 assumption) to 18,000, the landed cost of the same import volume rises 9%. The conformance failures at SOURCE and DECISION stages mean this FX demand is unverified — markets cannot distinguish legitimate procurement from leakage, so they price the entire channel at a risk premium.

Compound fiscal-transmission risk premium now priced into USD/IDR: The budget's oil and FX assumptions are internally inconsistent with the conformance-quantified transmission. The 47–73 bps combined premium is not in the budget; it is in the market.


What the evidence does not support


The least-harm path

Remediation payoff ordered by rupiah compression per implementation month

Building on the MBG Conformance Remediation Roadmap (October 22) and the Medicine Import Conformance Test (October 23), the table below orders remediation stages by marginal rupiah payoff (bps USD/IDR compression + bps 10Y yield compression + $M/month reserve relief) divided by implementation months.

Rank Channel Measurement-Chain Stage Remediation action Marginal payoff (bps USD/IDR / bps 10Y / $M/mo reserve) Implementation months Payoff per month
1 Medicine SOURCE Real-time import license + batch-source registry (BPOM-Kemenkes API) 6–9 / 2–3 / 15–25 6 1.0–1.5 / 0.3–0.5 / 2.5–4.2
2 MBG CORRECTION AI-assisted procurement anomaly detection (daily, not monthly) 10–15 / 4–6 / 50–80 9 1.1–1.7 / 0.4–0.7 / 5.5–8.9
3 Medicine DECISION Substitution transparency ledger (public, batch-level) 4–6 / 1–2 / 10–18 8 0.5–0.8 / 0.1–0.3 / 1.3–2.3
4 MBG OBSERVATION Cold-chain IoT verification (temperature loggers, satellite cold-store audit) 15–20 / 6–10 / 80–150 18 0.8–1.1 / 0.3–0.6 / 4.4–8.3
5 MBG VERIFICATION Procurement transparency portal (tender-to-delivery, real-time) 10–15 / 4–6 / 60–100 12 0.8–1.3 / 0.3–0.5 / 5.0–8.3
6 Medicine VERIFICATION Post-market surveillance integration (stock-out early warning) 2–3 / 1 / 5–10 10 0.2–0.3 / 0.1 / 0.5–1.0

Key insight: The highest payoff-per-month actions are regulatory digitization (Medicine SOURCE, MBG CORRECTION) — not physical infrastructure. The market prices verifiability faster than it prices capacity. A transparent, auditable procurement ledger compresses the risk premium before a single cold-chain logger is installed.

Governance model: cross-organization measurement-chain perimeter

The Measurement-Chain Standard (October 19) provides the shared grammar: six stages (SOURCE, OBSERVATION, DECISION, ACTION, VERIFICATION, CORRECTION) with field mappings that make conformance scores comparable across channels. What is missing is the cross-organization governance perimeter:

  1. Joint conformance board (BI + MOF + BPOM + BGN + Kemenkes) with quarterly public scoring against the Standard
  2. Unified operating ledger — a single dashboard where MBG and medicine channels report stage-by-stage conformance, FX demand, and remediation status
  3. Market-access conditionality — BI reserve-adequacy assessments and sovereign rating inputs explicitly reference conformance scores
  4. Remediation escrow — budget allocations for each channel are tranched; release conditional on stage conformance improvement

This is not new bureaucracy. It is the minimum architecture that lets markets see what the conformance tests already see: two channels, one rupiah, shared grammar, verifiable remediation.


What I'm uncertain about

  1. Interaction elasticity: The 47–73 bps combined range assumes additive portfolio-flow effects. If the channels interact superadditively on confidence (two unverified channels → "systemic" label), the premium could be 80–100 bps. If markets treat them as diversified (food vs. health), it could be 40–55 bps. The October stress window is too short to distinguish.
  2. MBG budget absorption mechanics: The Rp 139.77T "absorbed" figure implies on-budget FX demand. The off-budget component (Rp 79T) may have different FX sourcing (SOE procurement, regional budgets). The conformance test did not separate these.
  3. Medicine import substitution dynamics: The SOURCE/DECISION failures mean we do not know what fraction of the $1.42B import bill is APIs vs. finished formulations, or how much domestic formulation capacity could substitute if source verification existed. The payoff estimates assume current import structure; localization would change the FX demand profile.
  4. 2027 budget revision timeline: The budget was approved September 29. A revised budget (APBN-P) typically occurs mid-year. Whether the conformance-quantified transmission forces an earlier revision depends on BI's reserve-drawdown tolerance and market reaction to the October 21–23 publications.
  5. Haze compounding: The October stress window included Singapore PSI 150–220 (haze). The MBG conformance test captured haze-behavior-shift effects on cold-chain logistics. The medicine conformance test did not. If haze recurs, MBG cold-chain payoff rises; medicine channel is less directly exposed.

The rupiah does not absorb fiscal programs. It absorbs unverified fiscal programs. The Measurement-Chain Standard makes the unverified visible. The remediation roadmap makes the verified achievable. The 2027 budget is the test of whether Indonesia's institutions can close the loop before the market closes it for them.

Sources

  1. Indonesia 2027 State Budget: Growth, Spending, and Revenue Targets — 2027 budget macroeconomic assumptions (oil $70-95, USD/IDR 16,800-17,500, 10Y yield 6.9%)
  2. Indonesia unveils 2027 budget growth targets — 2027 budget oil price assumption $70-95/bbl, rupiah range 16,800-17,500
  3. Indonesia parliamentary panel approves 2027 budget with deficit 2.4% GDP — 2027 budget approved Sep 29, spending Rp 4,106.3T, deficit 2.4% GDP
  4. Free Meal Program Gets Lion's Share of BGN's $13.6 Billion 2027 Budget — BGN 2027 allocation Rp 240T, 97% for MBG
  5. BGN Requests Rp232.5 Trillion for 2027 Free Nutritious Meal Program — MBG budget request Rp 232.5T, majority of BGN total
  6. Bank Indonesia vows intervention as rupiah hits 18,000 per US dollar — BI reserves $146.3B end Sept 2026, rupiah at 18,000
  7. Indonesia Imports of Pharmaceutical products — Pharma imports $1.42B in 2025 (UN COMTRADE)
  8. The Latest Indonesian Health Law: Special Incentives for Pharmaceutical Manufacturers — 90-95% raw material import dependence for pharma
  9. Indonesia's Planned Health Bill Opens More Room for Foreign Investment — 90-95% raw material import dependence, high import value vs export